Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
BLCO
)
15.41
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about BLCO
< Previous
1
2
3
Next >
American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday
May 06, 2024
Via
Benzinga
BLCO Stock Earnings: Bausch & Lomb Meets EPS, Misses Revenue for Q1 2024
May 01, 2024
BLCO stock results show that Bausch & Lomb met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
May 01, 2024
A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASDAQ:AMD)
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Barclays Maintains Equal-Weight Rating for Bausch & Lomb: Here's What You Need To Know
February 26, 2024
Via
Benzinga
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 21, 2024
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...
Via
Benzinga
Eye Care-Focused Bausch + Lomb's Stock Surges On Upbeat Annual Guidance Despite Deeper Losses
February 21, 2024
Bausch + Lomb achieves Q4 2023 sales of $1.173 billion, exceeding expectations with an 18% YoY growth. CEO Brent Saunders anticipates robust growth in 2024, projecting sales of $4.6-$4.7 billion and an...
Via
Benzinga
Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday
February 21, 2024
U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For February 21, 2024
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
Bausch & Lomb Earnings Preview
February 20, 2024
Via
Benzinga
Wall Street Waits With Bated Breath For Nvidia Earnings After Tech Selloff, Fed Minutes Eyed: Analyst Flags This As Biggest Risk For Market
February 21, 2024
The market will broaden the sustenance of its rally when interest-rate cuts begin to be priced in and investors begin to think about the roadmap, an analyst said.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month
February 09, 2024
"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins...
Via
Benzinga
The Latest Analyst Ratings for Bausch & Lomb
December 04, 2023
Via
Benzinga
Bausch & Lomb Earnings Preview
October 31, 2023
Via
Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
6 Analysts Have This to Say About Bausch & Lomb
October 03, 2023
Via
Benzinga
Earnings Preview: Bausch & Lomb
August 01, 2023
Via
Benzinga
Analyst Ratings for Bausch & Lomb
July 24, 2023
Via
Benzinga
Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News'
November 01, 2023
U.S. stocks could start Wednesday's session lower as traders stay cautious ahead of the Fed decision and more earnings.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Novartis Mulls Divesting Some Assets Of Radiopharma Unit In Strategic Shift
October 03, 2023
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) is reportedly contemplating selling sections of radiopharmaceuticals company Advanced Accelerator Applications to align with the company's strategy...
Via
Benzinga
Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink
July 06, 2023
Bausch + Lomb Corporation (NYSE: BLCO) has acquired Johnson & Johnson's (NYSE: JNJ) eye and contact lens drops brand Blink for $106.5 million to bolster its position in over-the-counter (OTC)...
Via
Benzinga
Analyst Ratings for Bausch & Lomb
July 03, 2023
Via
Benzinga
9 Analysts Have This to Say About Bausch & Lomb
May 19, 2023
Via
Benzinga
Looking Into Bausch & Lomb's Return On Capital Employed
May 12, 2023
Via
Benzinga
Bausch & Lomb's Return On Capital Employed Insights
May 09, 2023
Via
Benzinga
Inflationary Factors And Slow Product Uptake Could Be Headwinds For Bausch + Lomb, Analyst Says
May 08, 2023
Via
Benzinga
Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday
June 30, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Amazon Hires Dozens of Former FTC Officials, Volkswagen Discusses With Tesla to Adopt North American Charging Standard, FDA Approves First Hemophilia A BioMarin Gene Therapy: Today's Top Stories
June 30, 2023
New York Post
Via
Benzinga
Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis
June 30, 2023
Bausch + Lomb Corporation (NYSE: BLCO) has agreed to acquire 'front of eye' ophthalmology assets for $1.75 billion in upfront cash, plus additional milestone payments from Novartis AG (NYSE:
Via
Benzinga
Recap: Bausch & Lomb Q1 Earnings
May 03, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.